Literature DB >> 19423615

Activation of a prometastatic gene expression program in hypoxic neuroblastoma cells.

Preamrudee Poomthavorn1, Sheena H X Wong, Sandra Higgins, George A Werther, Vincenzo C Russo.   

Abstract

The hypoxia inducible factor-1alpha (HIF1alpha) is a key regulator of oxygen homeostasis, modulating cell survival, and growth in cells exposed to hypoxia. In this study, neuroblastoma (NB) cells SH-SY5Y and SK-N-MC were employed to determine the mechanisms regulating adaptation to hypoxia. NB cells were cultured in a serum-free medium in the presence or absence of CoCl(2) (100 muM, hypoxia mimic) for up to 48 h. SH-SY5Y and SK-N-MC cell numbers were not affected by CoCl(2) treatment, while mitochondrial activity was reduced by approximately 50% in SH-SY5Y cells and by approximately 70% in SK-N-MC cells. Intracellular accumulation of HIF1alpha protein was detected as early as 30 min of post-hypoxia, followed by the increase of mRNA for vascular endothelial growth factor (VEGF) and nuclear accumulation of the ID1-2 transcription factors by 4 h. In hypoxic SH-SY5Y NB cells, real-time PCR analysis showed that the genes involved in maintenance of cell-cell and cell-matrix interactions (i.e. adenomatosis polyposis coli, E-cadherin, catenin, EphB2, fibronectin-1, HTATIP2, tissue inhibitor of metalloprotease-4) were down-regulated by up to 90%, while genes involved in enhancement of metastatic behavior (integrin a7b1, hepatocyte growth factor receptor, transforming growth factor-beta1, VEGF, kisspeptin, interleukin-1beta) were dramatically up-regulated above 200%. These changes were all consistent with the induction of epithelial-mesenchymal transition. We have thus demonstrated that NB cell adaptation to hypoxia, in addition to the modulation of HIF1alpha and VEGF expression and nuclear translocation of ID1 and ID2 transcription factors, involve in the activation of a gene expression program consistent with the pro-metastatic events. These processes are probably responsible for the NB cell transition from an adherent phenotype to a highly migratory, invasive and aggressive NB cell type.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19423615     DOI: 10.1677/ERC-08-0340

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  16 in total

1.  Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2.

Authors:  Jürgen Becker; Helena Pavlakovic; Fabian Ludewig; Fabiola Wilting; Herbert A Weich; Romulo Albuquerque; Jayakrishna Ambati; Jörg Wilting
Journal:  Clin Cancer Res       Date:  2010-02-23       Impact factor: 12.531

2.  Kisspeptin prevention of amyloid-β peptide neurotoxicity in vitro.

Authors:  Nathaniel G N Milton; Amrutha Chilumuri; Eridan Rocha-Ferreira; Amanda N Nercessian; Maria Ashioti
Journal:  ACS Chem Neurosci       Date:  2012-05-30       Impact factor: 4.418

3.  IGFBP-2 - taking the lead in growth, metabolism and cancer.

Authors:  Steven W Yau; Walid J Azar; Matthew A Sabin; George A Werther; Vincenzo C Russo
Journal:  J Cell Commun Signal       Date:  2015-01-25       Impact factor: 5.782

4.  Extracellular matrix rigidity modulates neuroblastoma cell differentiation and N-myc expression.

Authors:  Wilbur A Lam; Lizhi Cao; Vaibhavi Umesh; Albert J Keung; Shamik Sen; Sanjay Kumar
Journal:  Mol Cancer       Date:  2010-02-10       Impact factor: 27.401

5.  Identification of novel biomarkers in neuroblastoma associated with the risk for bone marrow metastasis: a pilot study.

Authors:  J Osman; S Galli; M Hanafy; X Tang; A Ahmed
Journal:  Clin Transl Oncol       Date:  2013-04-04       Impact factor: 3.405

6.  Effects of fluctuating glucose levels on neuronal cells in vitro.

Authors:  Vincenzo C Russo; Sandra Higgins; George A Werther; Fergus J Cameron
Journal:  Neurochem Res       Date:  2012-05-08       Impact factor: 3.996

7.  Reversible adaptive plasticity: a mechanism for neuroblastoma cell heterogeneity and chemo-resistance.

Authors:  Lina Chakrabarti; Thamara Abou-Antoun; Stanislav Vukmanovic; Anthony D Sandler
Journal:  Front Oncol       Date:  2012-08-02       Impact factor: 6.244

8.  Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy.

Authors:  Eduardo Castañon; Joaquim Bosch-Barrera; Inés López; Víctor Collado; Marta Moreno; José María López-Picazo; Leire Arbea; María Dolores Lozano; Alfonso Calvo; Ignacio Gil-Bazo
Journal:  J Transl Med       Date:  2013-01-11       Impact factor: 5.531

9.  A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients.

Authors:  Paolo Fardin; Annalisa Barla; Sofia Mosci; Lorenzo Rosasco; Alessandro Verri; Rogier Versteeg; Huib N Caron; Jan J Molenaar; Ingrid Ora; Alessandra Eva; Maura Puppo; Luigi Varesio
Journal:  Mol Cancer       Date:  2010-07-12       Impact factor: 27.401

10.  Direct observation of single amyloid-β(1-40) oligomers on live cells: binding and growth at physiological concentrations.

Authors:  Robin D Johnson; Joseph A Schauerte; Kathleen C Wisser; Ari Gafni; Duncan G Steel
Journal:  PLoS One       Date:  2011-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.